Withdrawn trial: experimental drug aimed to stop dangerous blood clots
NCT ID NCT07172022
Summary
This study aimed to test whether adding crovalimab to standard blood thinners could better prevent dangerous blood clots in people with antiphospholipid syndrome. The trial was designed for adults with a history of blood clots who were already taking blood-thinning medication. However, the study was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTIPHOSPHOLIPID SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.